Kayendeke M, Nabirye C, Nayiga S, Westercamp N, Gonahasa S, Katureebe A
Malar J. 2023; 22(1):244.
PMID: 37626312
PMC: 10463640.
DOI: 10.1186/s12936-023-04669-1.
Wagner L, Minnis A, Shea J, Agot K, Ahmed K, van der Straten A
PLoS One. 2022; 17(5):e0265303.
PMID: 35551318
PMC: 9097999.
DOI: 10.1371/journal.pone.0265303.
Rousseau E, Katz A, ORourke S, Bekker L, Delany-Moretlwe S, Bukusi E
PLoS One. 2021; 16(10):e0258542.
PMID: 34648589
PMC: 8516266.
DOI: 10.1371/journal.pone.0258542.
Miller L, Morar N, Kapiga S, Ramjee G, Hayes R
J Acquir Immune Defic Syndr. 2020; 85(4):458-465.
PMID: 33136745
PMC: 7993915.
DOI: 10.1097/QAI.0000000000002463.
Eakle R, Weatherburn P, Bourne A
J Int AIDS Soc. 2019; 22 Suppl 4:e25306.
PMID: 31328429
PMC: 6643067.
DOI: 10.1002/jia2.25306.
Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
Pleasants E, Tauya T, Reddy K, Mirembe B, Woeber K, Palanee-Phillips T
AIDS Behav. 2019; 24(3):866-880.
PMID: 31111297
PMC: 6864230.
DOI: 10.1007/s10461-019-02521-9.
Sexual and reproductive self care among women and girls: insights from ethnographic studies.
Hardon A, Pell C, Taqueban E, Narasimhan M
BMJ. 2019; 365:l1333.
PMID: 30936060
PMC: 6441865.
DOI: 10.1136/bmj.l1333.
Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.
Krogstad E, Montgomery E, Atujuna M, Minnis A, ORourke S, Ahmed K
AIDS Patient Care STDS. 2019; 33(4):157-166.
PMID: 30932697
PMC: 6459268.
DOI: 10.1089/apc.2018.0177.
Developing a culturally appropriate illustrated tool for the self-collection of anorectal specimens for the testing of sexually transmitted infections: lessons from Papua New Guinea.
Kelly-Hanku A, Bell S, Ase S, Boli-Neo R, Vallely A, Badman S
BMC Public Health. 2019; 19(1):214.
PMID: 30786882
PMC: 6383287.
DOI: 10.1186/s12889-019-6506-x.
Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa.
Duby Z, Mensch B, Hartmann M, Montgomery E, Mahaka I, Bekker L
Int J Sex Health. 2018; 29(3):247-257.
PMID: 30519370
PMC: 6276804.
DOI: 10.1080/19317611.2017.1297754.
Qualitative research on community experiences in large HIV research trials: what have we learned?.
Camlin C, Seeley J
J Int AIDS Soc. 2018; 21 Suppl 7:e25173.
PMID: 30334379
PMC: 6192898.
DOI: 10.1002/jia2.25173.
Six dimensions of research trial acceptability: how much, what, when, in what circumstances, to whom and why?.
Gooding K, Phiri M, Peterson I, Parker M, Desmond N
Soc Sci Med. 2018; 213:190-198.
PMID: 30142500
PMC: 7614255.
DOI: 10.1016/j.socscimed.2018.07.040.
Acceptability of testing for anorectal sexually transmitted infections and self-collected anal swabs in female sex workers, men who have sex with men and transgender women in Papua New Guinea.
Bell S, Wapling J, Ase S, Boli-Neo R, Vallely A, Kaldor J
BMC Public Health. 2018; 18(1):776.
PMID: 29925348
PMC: 6011240.
DOI: 10.1186/s12889-018-5684-2.
Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H
J Int AIDS Soc. 2018; 21(2).
PMID: 29457868
PMC: 5817972.
DOI: 10.1002/jia2.25081.
Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography.
Eakle R, Bourne A, Jarrett C, Stadler J, Larson H
BMC Public Health. 2017; 17(1):968.
PMID: 29258455
PMC: 5738143.
DOI: 10.1186/s12889-017-4959-3.
Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.
Laborde N, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M
AIDS Behav. 2017; 22(2):437-446.
PMID: 29151197
PMC: 5866044.
DOI: 10.1007/s10461-017-1977-1.
Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: A qualitative study.
McLellan-Lemal E, Ondenge K, Gust D, Desai M, Otieno F, Madiega P
Front Womens Health. 2017; 2(1).
PMID: 28845463
PMC: 5568572.
DOI: 10.15761/FWH.1000122.
Acceptability and use of a dapivirine vaginal ring in a phase III trial.
Montgomery E, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M
AIDS. 2017; 31(8):1159-1167.
PMID: 28441175
PMC: 5557083.
DOI: 10.1097/QAD.0000000000001452.
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett E, Lanham M, Wilcher R, Gafos M, Karim Q, Heise L
J Int AIDS Soc. 2015; 18:20536.
PMID: 26700845
PMC: 4689151.
DOI: 10.7448/IAS.18.1.20536.
Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
Rosen R, Berg J, Vargas S, Senocak N, Shaw J, Buckheit Jr R
Contraception. 2015; 92(6):596-601.
PMID: 26276246
PMC: 4664151.
DOI: 10.1016/j.contraception.2015.08.007.